Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
SLR Investment Corp
SLRC
$687M
| $5.75M | 0.01% |
363,239
+164,983
| +83% | +$2.91M |
|
|
CVRR
1252
CALL
DELISTED
CVR Refining, LP
CVRR
| $5.74M | 0.01% |
300,400
| – | – |
|
|
ALXN
1253
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.74M | 0.01% |
36,711
-1,255,262
| -97% | -$229M |
|
1254
Bunge Global
BG
$21.1B
| $5.72M | 0.01% |
+78,099
| New | +$6.04M |
|
1255
Huntington Ingalls Industries
HII
$11.4B
| $5.72M | 0.01% |
53,404
+20,249
| +61% | +$2.31M |
|
|
VAR
1256
DELISTED
Varian Medical Systems, Inc.
VAR
| $5.72M | 0.01% |
+88,369
| New | +$6.45M |
|
|
GI
1257
DELISTED
EndoChoice Holdings, Inc.
GI
| $5.72M | 0.01% |
503,267
+81,158
| +19% | +$1.27M |
|
1258
California Water Service
CWT
$3.11B
| $5.71M | 0.01% |
258,117
-38,298
| -13% | -$837K |
|
1259
Dollar General
DG
$27.1B
| $5.69M | 0.01% |
78,594
-182,698
| -70% | -$13.9M |
|
1260
PUT
American International
AIG
$40B
| $5.68M | 0.01% |
100,000
| – | – |
|
1261
Designer Brands
DBI
$285M
| $5.68M | 0.01% |
224,509
-2,160,280
| -91% | -$67.2M |
|
|
TGP
1262
DELISTED
Teekay LNG Partners L.P.
TGP
| $5.68M | 0.01% |
237,341
+212,385
| +851% | +$5.79M |
|
1263
PUT
Align Technology
ALGN
$11.3B
| $5.68M | 0.01% |
100,000
+50,000
| +100% | +$2.98M |
|
1264
CALL
iShares MSCI Brazil ETF
EWZ
$8.13B
| $5.66M | 0.01% |
+258,000
| New | +$6.88M |
|
1265
Becton Dickinson
BDX
$51.3B
| $5.65M | 0.01% |
43,647
+39,234
| +889% | +$5.48M |
|
|
PACW
1266
DELISTED
PacWest Bancorp
PACW
| $5.62M | 0.01% |
131,200
-147,767
| -53% | -$6.62M |
|
|
PERY
1267
DELISTED
Perry Ellis International Inc
PERY
| $5.62M | 0.01% |
255,730
+169,561
| +197% | +$4.03M |
|
1268
Suncor Energy
SU
$77.4B
| $5.61M | 0.01% |
210,009
-83,017
| -28% | -$2.23M |
|
|
SPNE
1269
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $5.6M | 0.01% |
+345,835
| New | +$5.65M |
|
1270
Vail Resorts
MTN
$5.27B
| $5.58M | 0.01% |
53,285
+10,146
| +24% | +$1.1M |
|
1271
VeriSign
VRSN
$26.4B
| $5.56M | 0.01% |
78,796
+55,023
| +231% | +$3.75M |
|
1272
MaxLinear
MXL
$5.94B
| $5.55M | 0.01% |
446,161
-87,676
| -16% | -$966K |
|
1273
WEC Energy
WEC
$34.8B
| $5.53M | 0.01% |
105,901
-142,841
| -57% | -$6.95M |
|
1274
PUT
Apple
AAPL
$4.52T
| $5.51M | 0.01% |
+200,000
| New | +$5.87M |
|
1275
FTI Consulting
FCN
$4.23B
| $5.51M | 0.01% |
132,711
-94,897
| -42% | -$3.9M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.